Genmab A/S Increase Decrease Through Net Exchange Differences Rightofuse Assets
Genmab A/S (GNMSF) reported Increase Decrease Through Net Exchange Differences Rightofuse Assets of $4.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets · last filed 2026-02-17
| Period end | Increase Decrease Through Net Exchange Differences Rightofuse Assets 12 month |
|---|---|
| 2025-12-31 | $4.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | -$7.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $4.00M 20-F · filed 2026-02-17 |